"Twelve months ago there was little evidence of potentially interested parties (pharma or government) in developing antimicrobials. I think that there is a now a greater sense of urgency."
Except of course PYC's collaboration with AstraZeneca in 2010 and the potential $100M deal they walked away from last year or early this year ? But in saying that Cubist have come for another look although no figures at all thrown up there...... yet
"Phylogica to Pursue Antimicrobial Peptide Discovery Through Licensing Agreement with Medimmune"
There where still deals going through in the anti-microbial space the last couple of years but granted it's been picking up again this year.
Rabbits out of hats 2014 ? :-)
PYC Price at posting:
1.7¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)